Respiratory Disposable Market Share Analysis Report, 2022-2030
The global Respiratory Disposable market size was estimated at USD 1.53 billion in 2021 and is expected to surpass around USD 4.57 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 12.93% during the forecast period 2022 to 2030.
Key Takeaways:
Respiratory disposables are consumables that are used to interface respiratory devices with patients, such as ventilators, nebulizers, and oxygen therapy devices. Respiratory disposables include disposable resuscitators, disposable oxygen masks, disposable tubes, and other or accessories. These products are disposables that can be cast-off after the deterioration of the material and can no longer be used.
The growth of the global respiratory disposables market is majorly driven by increase in risk of cross-contamination in infectious diseases, especially communicable lung disease.
In addition, the steep increase in smoking by individuals is likely to increase the prevalence of respiratory disorders, which, in turn, is anticipated to contribute toward the market growth in the coming years. The increased exposure to toxic materials such as pollutants and harmful particulate matters is further expected to propel the growth of the industry in the next few years. Moreover, upsurge in prevalence of respiratory diseases worldwide is anticipated to help the market gain traction in the coming years. Furthermore, adverse climate conditions and rise in air pollution are directly affecting the respiratory tract and causing distress in normal breathing. This eventually is increasing the incidence of respiratory diseases such as asthma, lung cancer, chronic obstructive pulmonary disease (COPD), and obstructive sleep apnea (OSA), which boost the demand for respiratory disposables.
However, implementation of stringent regulations related to the use of respiratory disposables hampers the growth of the respiratory disposables market. On the contrary, increase in advent of viruses that are causing respiratory disorders is projected to offer remunerative opportunity for the expansion of the global market during the forecast period.
The World Health Organization (WHO) on January 30, 2021 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The demand for respiratory disposables increased exponentially, owing to the outbreak of the coronavirus affecting the respiratory tract. For instance, medical professionals have increased the usage of nasal cannulas for the administration of drugs to combat COVID-19.
Report Scope of the Respiratory Disposable Market
|
Report Coverage |
Details |
|
Market Size in 2022 |
USD 1.73 Billion |
|
Market Size by 2030 |
USD 4.57 Billion |
|
Growth Rate from 2022 to 2030 |
CAGR of 12.93% |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product, Patient Group, End User, Application, Geography |
|
Companies Mentioned |
Fisher and Paykel Healthcare, Smith Group (Smith Medical Inc.), Hamilton Medical AG, Getinge AB, Invacare Corporation, Masimo Corporation, Medtronic Plc., Dragerwerk AG and CO. KGAA, Air liquid S.A, Chart Industries |
Product Insights
Due to increased demand has increased the revenue market share and imposed standardized guidelines for the development and manufacturing with increased research and development and improved advanced technologies and strategies adopted for the manufacturing and the output of the good productivity and quality of the product and uniformity of manufacturing companies and fulfilling’s the requirement of the market has boosted the respiratory disposable market growth.
Application Insights
On the basis of application respiratory disposable market has wide utilization in various fields. Majorly respiratory devices are used in the hospitals, by the patients with infected disease like asthma, obstructive pulmonary disease, lung cancer and many other respiratory infections used by the doctors in the hospitals during operations and the surgeries performed which has increased the market growth. Usage of the respiratory devices in industries such as food and beverages, pharmaceutical industries, chemical companies, oil and gases, power generation, metals and mining, automobile industries and many more. The development of various new advance technologies has gained the attention of the market and increased growth during the forecast period. Health sector has considerably shown rising peak and increasing economy.
Distribution Channel Insights
Improved developments of respiratory devices has flawlessly improved the market growth due to increasing demands across the regions. Increasing respiratory disorders among the population has increased the usage of respiratory disposable in the hospitals and among the patients. Usage of the product like laryngoscope, pulse oximeters, breathing bags, tubes, resuscitators, oxygen therapy, masks and many more. It is also used in various companies and industries such as chemical, pharmaceutical industries, metals, oil and gas, power generation, automobile industries and others with improved advance technology helped the market to grow.
Some of the prominent players in the Respiratory Disposable Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Respiratory Disposable market
By Product
By Patient Group
By End User
By Application
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Respiratory Disposable Market
5.1. COVID-19 Landscape: Respiratory Disposable Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Respiratory Disposable Market, By Product
8.1. Respiratory Disposable Market, by Product, 2022-2030
8.1.1. Laryngoscope
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Tubes
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Breathing Bag
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Masks
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Resuscitator
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Respiratory Disposable Market, By Patient Group
9.1. Respiratory Disposable Market, by Patient Group e, 2022-2030
9.1.1. Neonatal & Pediatric
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Adult
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Geriatric
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Respiratory Disposable Market, By End User
10.1. Respiratory Disposable Market, by End User, 2022-2030
10.1.1. Hospitals, Nursing Homes, & Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Trauma Centers
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Homecare
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Respiratory Disposable Market, By Application
11.1. Respiratory Disposable Market, by Application, 2022-2030
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Pharmaceuticals
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Cosmetics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Automobiles
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Metals
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Chemical Companies
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Health Sectors
11.1.7.1. Market Revenue and Forecast (2017-2030)
11.1.8. Power generation
11.1.8.1. Market Revenue and Forecast (2017-2030)
11.1.9. Oil and gases and other
11.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Respiratory Disposable Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Patient Group (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
Chapter 13. Company Profiles
13.1. Fisher and Paykel Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Smith Group (Smith Medical Inc.)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Hamilton Medical AG
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Getinge AB
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Invacare Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Masimo Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Medtronic Plc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Dragerwerk AG and CO. KGAA
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Air liquid S.A
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Chart Industries
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers